The
dilutive common shares that were used in the calculation of diluted earnings for 2023 are presented in the table below. The 2024 amounts
were not used as they were antidilutive.
Summary
of Dilutive Common Shares were Excluded from Calculation of Diluted
|
|
2024 |
|
|
2023 |
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2024 |
|
|
2023 |
|
Shares subject to options to purchase common stock |
|
|
5,164,508 |
|
|
|
5,729,215 |
|
Share-based Payment Arrangement, Option |
|
|
5,164,508 |
|
|
|
5,729,215 |
|
Unvested restricted stock units |
|
|
678,125 |
|
|
|
860,888 |
|
Shares subject to warrants to purchase common stock |
|
|
2 |
|
|
|
2 |
|
Total |
|
|
5,842,635 |
|
|
|
6,590,105 |
|
|